Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Divi's Laboratories Limited (NSE: DIVISLAB), ISIN INE361B01024 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
DIVISLAB last traded at ₹11547.00 (+4.06%), with a 52-week range of ₹5647.50 to ₹11824.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 51.88%, FIIs 20.38%, DIIs 19.08%, mutual funds 14.66%.
EquiSense Score (ECS): 85/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.